Evidence map›Paper›PMID 19471315›Full record

ArticleEuropean journal of human genetics : EJHG2009

Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice.

Annelien Bredenoord, Wybo Dondorp, Guido Pennings, Christine de Die-Smulders, Bert Smeets, Guido de Wert

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. A national perspective on prenatal testing for mitochondrial disease.European journal of human genetics : EJHG · 2014
    Article
  4. Review
  5. Review
  6. Ethics in prion disease.Progress in neurobiology · 2013
    Article
  7. Review
  8. Genomics and perinatal care.The New England journal of medicine · 2012
    Review
  9. Mitochondrial genetic diseases.Current opinion in pediatrics · 2010
    Review
  10. Article
  11. Review
  12. Mitochondrial energetics and therapeutics.Annual review of pathology · 2010
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Annelien BredenoordDepartment of Health, Ethics and Society, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. a.l.bredenoord@umcutrecht.nl
Wybo Dondorp
Guido Pennings
Christine de Die-Smulders
Bert Smeets
Guido de Wert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although morally acceptable in theory, preimplantation genetic diagnosis (PGD) for mitochondrial DNA (mtDNA) disorders raises several ethical questions in clinical practice. This paper discusses the major conditions for good clinical practice. Our starting point is that PGD for mtDNA mutations should as far as possible be embedded in a scientific research protocol. For every clinical application of PGD for mtDNA disorders, it is not only important to avoid a 'high risk of serious harm' to the future child, but also to consider to what extent it would be possible, desirable and proportional to try to reduce the health risks and minimize harm. The first issue we discuss is oocyte sampling, which may point out whether PGD is feasible for a specific couple. The second issue is whether one blastomere represents the genetic composition of the embryo as a whole -- and how this could (or should) be investigated. The third issue regards the cutoff points below which embryos are considered to be eligible for transfer. We scrutinize how to determine these cutoff points and how to use these cutoff points in clinical practice -- for example, when parents ask to take more or less risks. The fourth issue regards the number of cycles that can (or should) justifiably be carried out to find the best possible embryo. Fifth, we discuss whether follow-up studies should be conducted, particularly the genetic testing of children born after IVF/PGD. Finally, we offer the main information that is required to obtain a truly informed consent.

Indexed as

DNA, MitochondrialEmbryo ResearchFeasibility StudiesFemaleHumansInformed ConsentMitochondrial DiseasesMutationPractice Guidelines as TopicPregnancyPreimplantation DiagnosisReproductive Techniques, AssistedDNA, Mitochondrial

Identifiers

PMID19471315
PMCPMC2987024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.